AIMC Topic: Drug Discovery

Clear Filters Showing 161 to 170 of 1689 articles

TCoCPIn reveals topological characteristics of chemical protein interaction networks for novel feature discovery.

Scientific reports
Understanding chemical-protein interactions (CPIs) is crucial for drug discovery and biological research, yet their complexity often challenges traditional methods. We propose TCoCPIn, a novel framework integrating graph neural networks (GNN) with th...

Multi-filter based signed heterogeneous graph convolutional networks for predicting activating/inhibiting drug-target interactions.

Methods (San Diego, Calif.)
The prediction of mechanisms within drug-target interactions (DTIs) can boost the drug discovery process, which has traditionally relied on time-consuming and expensive laboratory experiments. Despite much more attention has been paid to predicting D...

Labels as a feature: Network homophily for systematically annotating human GPCR drug-target interactions.

Nature communications
Machine learning has revolutionized drug discovery by enabling the exploration of vast, uncharted chemical spaces essential for discovering novel patentable drugs. Despite the critical role of human G protein-coupled receptors in FDA-approved drugs, ...

Artificial-intelligence-driven Innovations in Mechanistic Computational Modeling and Digital Twins for Biomedical Applications.

Journal of molecular biology
Understanding of complex biological systems remains a significant challenge due to their high dimensionality, nonlinearity, and context-specific behavior. Artificial intelligence (AI) and mechanistic modeling are becoming essential tools for studying...

M3S-GRPred: a novel ensemble learning approach for the interpretable prediction of glucocorticoid receptor antagonists using a multi-step stacking strategy.

BMC bioinformatics
Accelerating drug discovery for glucocorticoid receptor (GR)-related disorders, including innovative machine learning (ML)-based approaches, holds promise in advancing therapeutic development, optimizing treatment efficacy, and mitigating adverse eff...

Machine learning: Python tools for studying biomolecules and drug design.

Molecular diversity
The increasing adoption of computational methods and artificial intelligence in scientific research has led to a growing interest in versatile tools like Python. In the fields of medical chemistry, biochemistry, and bioinformatics, Python has emerged...

Big data-driven target identification by machine learning: DRD2 as a therapeutic target for psoriasis.

Journal of dermatological science
BACKGROUND: The development of medical treatments has traditionally relied on researchers leveraging scientific knowledge to hypothesize disease mechanisms and identify therapeutic agents. However, the depletion of novel therapeutic targets has becom...

OPTUNA optimization for predicting chemical respiratory toxicity using ML models.

Journal of computer-aided molecular design
Predicting molecular toxicity is an important stage in the process of drug discovery. It is directly related to medical destiny and human health. This paper presents an enhanced model for chemical respiratory toxicity prediction. It used a combinatio...

The QDπ dataset, training data for drug-like molecules and biopolymer fragments and their interactions.

Scientific data
The development of universal machine learning potentials (MLP) for small organic and drug-like molecules requires large, accurate datasets that span diverse chemical spaces. In this study, we introduce the QDπ dataset which incorporates data taken fr...

KRN-DTI: Towards accurate drug-target interaction prediction with Kolmogorov-Arnold and residual networks.

Methods (San Diego, Calif.)
Predicting drug-target interactions (DTIs) accurately is essential in the field of drug discovery. Recently, artificial intelligence (AI) technologies, especially graph convolutional networks (GCNs), have been developed to tackle this challenge. Howe...